221 related articles for article (PubMed ID: 24739055)
21. 20-Week follow-up of hepatic steatosis installation and liver mitochondrial structure and activity and their interrelation in rats fed a high-fat-high-fructose diet.
Fouret G; Gaillet S; Lecomte J; Bonafos B; Djohan F; Barea B; Badia E; Coudray C; Feillet-Coudray C
Br J Nutr; 2018 Feb; 119(4):368-380. PubMed ID: 29498345
[TBL] [Abstract][Full Text] [Related]
22. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
[TBL] [Abstract][Full Text] [Related]
23. [Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice].
Chen XM; Li FQ; Yan S; Wu XC; Tang CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):777-782. PubMed ID: 27752155
[TBL] [Abstract][Full Text] [Related]
24. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling.
Yang W; Cao M; Mao X; Wei X; Li X; Chen G; Zhang J; Wang Z; Shi J; Huang H; Yao X; Liu C
Nutr Res; 2016 Jun; 36(6):586-93. PubMed ID: 27188904
[TBL] [Abstract][Full Text] [Related]
25. TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.
Liu H; Li J; Tillman B; Morgan TR; French BA; French SW
Exp Mol Pathol; 2014 Oct; 97(2):234-40. PubMed ID: 24997224
[TBL] [Abstract][Full Text] [Related]
26. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
Leung C; Herath CB; Jia Z; Andrikopoulos S; Brown BE; Davies MJ; Rivera LR; Furness JB; Forbes JM; Angus PW
World J Gastroenterol; 2016 Sep; 22(35):8026-40. PubMed ID: 27672297
[TBL] [Abstract][Full Text] [Related]
27. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease.
Jegatheesan P; Beutheu S; Ventura G; Sarfati G; Nubret E; Kapel N; Waligora-Dupriet AJ; Bergheim I; Cynober L; De-Bandt JP
Clin Nutr; 2016 Feb; 35(1):175-182. PubMed ID: 25736031
[TBL] [Abstract][Full Text] [Related]
28. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver.
Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP
Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520
[TBL] [Abstract][Full Text] [Related]
29. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis.
Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I
Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497
[TBL] [Abstract][Full Text] [Related]
30. Sulforaphane Ameliorates Nonalcoholic Fatty Liver Disease Induced by High-Fat and High-Fructose Diet via LPS/TLR4 in the Gut-Liver Axis.
Xu Y; Huang X; Huangfu B; Hu Y; Xu J; Gao R; Huang K; He X
Nutrients; 2023 Feb; 15(3):. PubMed ID: 36771448
[TBL] [Abstract][Full Text] [Related]
31. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
[TBL] [Abstract][Full Text] [Related]
32. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E deficiency and high-fat diet cooperate to trigger lipidosis and inflammation in the lung via the toll-like receptor 4 pathway.
Ouyang Q; Huang Z; Lin H; Ni J; Lu H; Chen X; Wang Z; Lin L
Mol Med Rep; 2015 Aug; 12(2):2589-97. PubMed ID: 25975841
[TBL] [Abstract][Full Text] [Related]
34. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
[TBL] [Abstract][Full Text] [Related]
35. Tlr4 upregulation in the brain accompanies depression- and anxiety-like behaviors induced by a high-cholesterol diet.
Strekalova T; Evans M; Costa-Nunes J; Bachurin S; Yeritsyan N; Couch Y; Steinbusch HM; Eleonore Köhler S; Lesch KP; Anthony DC
Brain Behav Immun; 2015 Aug; 48():42-7. PubMed ID: 25712260
[TBL] [Abstract][Full Text] [Related]
36. Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice.
Sellmann C; Baumann A; Brandt A; Jin CJ; Nier A; Bergheim I
J Nutr; 2017 Nov; 147(11):2041-2049. PubMed ID: 28931589
[No Abstract] [Full Text] [Related]
37. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway.
Ye M; Tang Y; He J; Yang Y; Cao X; Kou S; Wang L; Sheng L; Xue J
Clin Investig Arterioscler; 2021; 33(5):257-266. PubMed ID: 33810882
[TBL] [Abstract][Full Text] [Related]
38. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
Asano T; Watanabe K; Kubota N; Gunji T; Omata M; Kadowaki T; Ohnishi S
J Gastroenterol Hepatol; 2009 Oct; 24(10):1669-76. PubMed ID: 19788607
[TBL] [Abstract][Full Text] [Related]
39. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
40. Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice.
Jin CJ; Engstler AJ; Ziegenhardt D; Bischoff SC; Trautwein C; Bergheim I
J Gastroenterol Hepatol; 2017 Mar; 32(3):708-715. PubMed ID: 27404046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
